Skincare Regulatory Guide: ASEAN, EU & FDA Compliance in 2026

Why Regulatory Compliance Is Your Brand's Foundation

Regulatory compliance isn't bureaucracy — it's brand protection. One recall, one ingredient violation, one customs rejection can destroy years of brand building and cost tens of thousands in inventory write-offs. In 2025 alone, the EU Safety Gate (RAPEX) issued 387 alerts for cosmetic products, with the top violations being unauthorized ingredients, incorrect labeling, and microbial contamination.

For OEM/ODM brand owners, understanding the regulatory landscape of your target markets is essential before you even brief a manufacturer. Different regions have vastly different requirements for ingredient restrictions, labeling, claims substantiation, and registration. This guide maps the three most critical regulatory frameworks for global skincare brands — ASEAN, EU, and US FDA — with practical steps for compliance at each stage of product development.

Regulatory Framework 1: ASEAN Cosmetic Directive (ACD)

The ASEAN Cosmetic Directive, implemented in 2008 and continuously updated, harmonizes cosmetics regulation across all 10 ASEAN member states: Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam. With a combined population of over 670 million and a skincare market exceeding $12 billion, ASEAN is arguably the most important regulatory regime for brands manufacturing in or exporting to Southeast Asia.

Key Principles of the ACD

• Notification, Not Approval: Products must be notified to each country's regulatory authority before market entry, but pre-market approval is not required (unlike pharmaceuticals). The responsible person — typically the brand owner or local distributor — submits the notification.
• Ingredient-Based Regulation: The ACD maintains Annexes listing prohibited substances (over 1,400), restricted substances (with concentration limits and usage conditions), permitted preservatives, permitted UV filters, and permitted colorants. If your ingredient isn't on any list, it's generally permitted — but safety substantiation is still required.
• INCI Labeling: All ingredients must be listed using International Nomenclature of Cosmetic Ingredients (INCI) names, in descending order of concentration (ingredients below 1% can be in any order).
• Product Information File (PIF): A comprehensive dossier including product formula, specifications, manufacturing method, safety assessment, and proof of claimed effects must be maintained and made available to authorities upon request.

Country-Specific Nuances

Regulatory Framework 2: EU Cosmetics Regulation (EC 1223/2009)

The EU Cosmetics Regulation is widely considered the global gold standard for cosmetic safety. It operates on a Responsible Person model — every cosmetic product placed on the EU market must have a designated Responsible Person (manufacturer, importer, or authorized representative based in the EU) who ensures compliance.

Core Requirements

• Cosmetic Product Safety Report (CPSR): Every product requires a CPSR signed by a qualified safety assessor with a degree in pharmacy, toxicology, dermatology, medicine, or equivalent. The CPSR includes Part A (safety information) and Part B (safety assessment).
• CPNP Notification: Before market entry, products must be notified via the EU Cosmetic Products Notification Portal (CPNP). This is a centralized electronic system. Unlike ASEAN, notification in one EU country covers all 27 member states.
• Claims Substantiation: The EU's Common Criteria for cosmetic claims (2013/674/EU) requires that all product claims be supported by adequate and verifiable evidence. "Clinically proven," "dermatologically tested," and similar claims require documented testing.
• Animal Testing Ban: The EU has prohibited animal testing for cosmetics and cosmetic ingredients since 2013. Brands must ensure their entire supply chain complies.
• Nanomaterial Labeling: Ingredients present as nanomaterials must be labeled with "(nano)" after the INCI name and notified separately in CPNP.

2025–2026 Regulatory Updates

Several ingredient restrictions have tightened: the maximum concentration of Salicylic Acid in leave-on products is now 0.5% (down from 2.0% in some categories); Retinol equivalents are capped at 0.3% in face products; and several cyclic silicones (D4, D5, D6) face phase-out timelines. Brands should review formulations quarterly against updated SCCS opinions.

Regulatory Framework 3: US FDA & MoCRA

The US regulatory landscape transformed dramatically with the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022 and fully enforced from 2024 onward. For the first time, the FDA has mandatory recall authority, facility registration requirements, and adverse event reporting obligations for cosmetics.

MoCRA's Key Requirements

1. Facility Registration: Every cosmetic manufacturing facility must register with the FDA and renew biennially. Foreign facilities must also designate a US Agent.
2. Product Listing: Each cosmetic product must be listed with the FDA, including ingredients, responsible person details, and facility registration number.
3. Adverse Event Reporting: Serious adverse events must be reported to the FDA within 15 business days. Records must be maintained for 6 years.
4. Safety Substantiation: Brands must maintain records demonstrating "adequate substantiation of safety" — a significant shift from the previous system where safety substantiation was expected but not explicitly mandated.
5. Professional Use Labeling: Products intended for professional use only must clearly state this on the label.
6. Fragrance Allergen Disclosure: By 2025–2026, the FDA is expected to finalize rules requiring disclosure of fragrance allergens on product labels.

GMP Requirements Under MoCRA

The FDA is developing mandatory GMP regulations for cosmetics, aligning with ISO 22716. UbitGlow's GMP-certified facility already meets these emerging standards, giving our OEM partners a head start on compliance.

How OEM Partners Simplify Regulatory Compliance

Working with an experienced OEM/ODM manufacturer dramatically reduces your regulatory burden. Here's what UbitGlow provides as part of our compliance package:

• GMP-Certified Manufacturing: ISO 22716:2007 certification, accepted globally as the gold standard for cosmetic manufacturing.
• Safety Assessment Support: We coordinate with certified safety assessors in your target markets to produce CPSRs, PIFs, and safety dossiers.
• Stability & Challenge Testing: Accelerated stability testing (3 months at 40°C/75% RH), microbiological challenge testing (PET), and compatibility testing — all documented for regulatory submissions.
• Ingredient Compliance Screening: Every formulation is screened against prohibited and restricted substance lists for your target markets before production begins.
• Labeling Review: INCI compliance, language requirements, and mandatory labeling elements verified for each target market.
• Notification Filing: Support with product notification/registration in ASEAN countries, EU CPNP, and US FDA product listing.

Frequently Asked Questions